Trial Profile
Optimal Duration of Olanzapine Add-on Therapy in Major Depression: a Placebo-controlled, Randomized, Phase III, Pilot Study in Parallel Group Design
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 13 Feb 2023
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms OLA-D
- 26 Apr 2008 Status changed from recruiting to withdrawn prior to recruitment.
- 24 Dec 2007 New trial record.